Published in J Acquir Immune Defic Syndr on December 01, 2006
Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT) (ADEPTT) | NCT03302299
Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet (2011) 5.34
Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis (2011) 3.63
Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia. PLoS One (2008) 2.41
Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. J Acquir Immune Defic Syndr (2011) 1.98
Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clin Infect Dis (2011) 1.70
Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS (2009) 1.68
The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Acquir Immune Defic Syndr (2013) 1.63
Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity. Ann Behav Med (2014) 1.58
Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa. AIDS Res Treat (2012) 1.51
A proposal for quality standards for measuring medication adherence in research. AIDS Behav (2013) 1.51
Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med (2015) 1.45
Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP). PLoS One (2014) 1.35
Predictors of adherence to inhaled medications among Veterans with COPD. J Gen Intern Med (2012) 1.33
Effect of computer-assisted interviewing on self-reported sexual behavior data in a microbicide clinical trial. AIDS Behav (2013) 1.32
Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study. J Acquir Immune Defic Syndr (2010) 1.27
Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting. AIDS Behav (2011) 1.21
Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya. J Acquir Immune Defic Syndr (2014) 1.16
The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review. J Behav Med (2009) 1.14
MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav (2013) 1.14
Comparison of antiretroviral adherence questions. AIDS Behav (2012) 1.14
Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics. Contemp Clin Trials (2009) 1.13
The accuracy of self-reported drug ingestion histories in emergency department patients. J Clin Pharmacol (2014) 1.11
Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve, HIV patients. HIV Clin Trials (2011) 1.10
Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. J Infect Dis (2010) 1.09
Livelihood security and adherence to antiretroviral therapy in low and middle income settings: a systematic review. PLoS One (2011) 1.09
Short communication: A low-cost method for analyzing nevirapine levels in hair as a marker of adherence in resource-limited settings. AIDS Res Hum Retroviruses (2013) 1.06
Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice. Curr Opin HIV AIDS (2016) 1.04
Relationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection. AIDS Care (2013) 1.03
Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence. AIDS Behav (2008) 1.01
Personality and medication non-adherence among older adults enrolled in a six-year trial. Br J Health Psychol (2011) 1.01
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study. J Acquir Immune Defic Syndr (2014) 1.00
Correlates of stigma among rural Indian women living with HIV/AIDS. AIDS Behav (2013) 1.00
Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trials. Sex Transm Dis (2013) 0.98
Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. J Acquir Immune Defic Syndr (2015) 0.96
Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. BMC Public Health (2014) 0.96
Correlation between pill counts and biologic effects in an HIV-1 prevention clinical trial: implications for measuring adherence. AIDS Behav (2013) 0.96
Association of first-line and second-line antiretroviral therapy adherence. Open Forum Infect Dis (2014) 0.95
Impact of a rural village women (Asha) intervention on adherence to antiretroviral therapy in southern India. Nurs Res (2012) 0.95
Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women. AIDS (2015) 0.94
Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System. BMC Public Health (2011) 0.93
Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules. BMC Med (2009) 0.93
Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness. J Acquir Immune Defic Syndr (2015) 0.93
Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol. BMJ Open (2013) 0.91
Feasibility, performance, and acceptability of the Wisebag™ for potential monitoring of daily gel applicator use in Durban, South Africa. AIDS Behav (2013) 0.91
Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots. J Pharm Biomed Anal (2016) 0.90
Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges. AIDS Rev (2013) 0.88
Impact of an Asha intervention on depressive symptoms among rural women living with AIDS in India: comparison of the Asha-Life and Usual Care program. AIDS Educ Prev (2012) 0.88
Treatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa. PLoS One (2011) 0.88
Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda. AIDS Care (2014) 0.88
Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected women. AIDS Res Hum Retroviruses (2014) 0.87
Using Lopinavir Concentrations in Hair Samples to Assess Treatment Outcomes on Second-Line Regimens Among Asian Children. AIDS Res Hum Retroviruses (2015) 0.87
Approaches for informing optimal dose of behavioral interventions. Ann Behav Med (2014) 0.86
Clinical and immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa. BMC Infect Dis (2014) 0.85
Measuring adherence to antiretroviral therapy in children and adolescents in western Kenya. J Int AIDS Soc (2014) 0.84
Impact of Asha intervention on stigma among rural Indian women with AIDS. West J Nurs Res (2013) 0.84
Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitibine as Pre-exposure Prophylaxis (Prep) Clinical Trial, Botswana, 2007-2010. AIDS Behav (2015) 0.84
An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. J Acquir Immune Defic Syndr (2017) 0.84
Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients. PLoS One (2015) 0.83
Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting. AIDS Behav (2013) 0.83
Correlates of Adherence among Rural Indian Women Living with HIV/AIDS. J HIV AIDS Soc Serv (2012) 0.82
Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention. AIDS Behav (2015) 0.82
Older Adults Accessing HIV Care and Treatment and Adherence in the IeDEA Central Africa Cohort. AIDS Res Treat (2012) 0.82
Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in urban Zambia. AIDS Res Hum Retroviruses (2013) 0.82
Factors Influencing Antiretroviral Adherence and Virological Outcomes in People Living with HIV in the Highlands of Papua New Guinea. PLoS One (2015) 0.81
Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia. J Int AIDS Soc (2014) 0.81
Measuring Patient Adherence to Malaria Treatment: A Comparison of Results from Self-Report and a Customised Electronic Monitoring Device. PLoS One (2015) 0.80
Clustering based on adherence data. Epidemiol Perspect Innov (2011) 0.80
Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life. BMC Pediatr (2015) 0.80
Correlates of depression among rural women living with AIDS in Southern India. Issues Ment Health Nurs (2011) 0.80
Monitoring microbicide gel use with real-time notification of the container's opening events: results of the CAPRISA Wisebag study. AIDS Behav (2014) 0.79
Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study. Lancet HIV (2016) 0.78
Comprehensive evaluation of caregiver-reported antiretroviral therapy adherence for HIV-infected children. AIDS Behav (2015) 0.78
The efficacy of a computerized assessment of medication adherence in active substance users. J Int Assoc Provid AIDS Care (2013) 0.77
A Self-Reported Adherence Measure to Screen for Elevated HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy. AIDS Behav (2016) 0.77
Conceptualisations of masculinity and self-reported medication adherence among HIV-positive Latino men in Los Angeles, California, USA. Cult Health Sex (2014) 0.77
Characterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions. Patient Prefer Adherence (2014) 0.77
Contingency management facilitates the use of postexposure prophylaxis among stimulant-using men who have sex with men. Open Forum Infect Dis (2015) 0.77
Medical mistrust as a key mediator in the association between perceived discrimination and adherence to antiretroviral therapy among HIV-positive Latino men. J Behav Med (2017) 0.76
Antiretroviral therapy adherence strategies used by patients of a large HIV clinic in Lesotho. J Health Popul Nutr (2015) 0.76
Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial. AIDS Behav (2014) 0.76
What Time is it? Adherence to Antiretroviral Therapy in Ethiopia. AIDS Behav (2016) 0.76
Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China. PLoS One (2016) 0.75
Random lopinavir concentrations predict resistance on lopinavir-based antiretroviral therapy. Int J Antimicrob Agents (2016) 0.75
Predictive validity of a brief antiretroviral adherence index: retrospective cohort analysis under conditions of repetitive administration. AIDS Res Ther (2008) 0.75
Children and Adolescents with Perinatal HIV-1 Infection: Factors Associated with Adherence to Treatment in the Brazilian Context. Int J Environ Res Public Health (2016) 0.75
Brief Report: Apparent Antiretroviral Overadherence by Pill Count is Associated With HIV Treatment Failure in Adolescents. J Acquir Immune Defic Syndr (2016) 0.75
Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants? BMC Pediatr (2015) 0.75
The adherence-outcome relationship is not altered by diary-driven adjustments of microelectronic monitor data. Pharmacoepidemiol Drug Saf (2015) 0.75
Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance. AIDS Behav (2017) 0.75
Reduced adherence to antiretroviral therapy is associated with residual low-level viremia. Pragmat Obs Res (2017) 0.75
Defining a cut-off for atazanavir in hair samples associated with virological failure among adolescents failing second-line antiretroviral treatment. J Acquir Immune Defic Syndr (2017) 0.75
Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study. BMC Infect Dis (2017) 0.75
Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care (2004) 12.32
A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med (2001) 9.98
The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol (1997) 8.88
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (2000) 8.86
Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav (2006) 8.11
Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol (2000) 7.77
Patient adherence and medical treatment outcomes: a meta-analysis. Med Care (2002) 7.10
How often is medication taken as prescribed? A novel assessment technique. JAMA (1989) 5.98
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS (2005) 5.09
A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care (1988) 4.71
Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr (2004) 4.58
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis (2002) 4.43
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS (2002) 4.42
Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med (2004) 4.17
Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 3.86
Compliance declines between clinic visits. Arch Intern Med (1990) 3.84
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials (2004) 3.75
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med (2001) 3.74
The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns (1999) 3.45
Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev (2002) 3.45
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ (2003) 3.19
Effect of computer-assisted self-interviews on reporting of sexual HIV risk behaviours in a general population sample: a methodological experiment. AIDS (2001) 3.03
A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol (2004) 2.97
Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr (2000) 2.94
Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr (2005) 2.75
Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr (2006) 2.65
Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis (2004) 2.33
The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther (1989) 2.29
Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav (2005) 2.18
Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med (2003) 2.18
Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr (2003) 2.15
Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. J Clin Epidemiol (2001) 2.09
Therapeutic drug monitoring in HIV infection: current status and future directions. AIDS (2002) 2.08
Is the influence of social desirability on patients' self-reported adherence overrated? J Acquir Immune Defic Syndr (2004) 2.03
Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother (2001) 2.03
Cognitive psychology and self-reports: models and methods. Qual Life Res (2003) 1.98
Validity of the Fagerström test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction (1999) 1.96
Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STDS (2002) 1.89
Time to stop counting the tablets? Clin Pharmacol Ther (1989) 1.88
The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr (2004) 1.82
Measurement of adherence to antiretroviral medications. J Acquir Immune Defic Syndr (2002) 1.78
Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care STDS (2004) 1.75
Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs (1995) 1.75
Electronic monitoring and counseling to improve medication adherence. Behav Res Ther (2004) 1.73
Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr (2002) 1.70
Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill. Antivir Ther (2003) 1.70
Position paper on therapeutic drug monitoring of antiretroviral agents. AIDS Res Hum Retroviruses (2002) 1.66
Generic health measurement: past accomplishments and a measurement paradigm for the 21st century. Ann Intern Med (1997) 1.63
Measuring medication adherence: are missed doses reported more accurately then perfect adherence? AIDS Care (2000) 1.56
Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Read (1999) 1.53
Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting. HIV Med (2005) 1.51
Electronic monitoring: adherence assessment or intervention? HIV Clin Trials (2002) 1.50
Emergence of item response modeling in instrument development and data analysis. Med Care (2000) 1.49
Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care STDS (2005) 1.44
Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible. AIDS Patient Care STDS (2004) 1.43
Modeling sources of self-report bias in a survey of drug use epidemiology. Ann Epidemiol (2005) 1.43
A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy. AIDS Care (2002) 1.36
A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence. Drug Alcohol Depend (2005) 1.35
Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clin Infect Dis (2003) 1.33
Patterns of adherence to antiretroviral medications: the value of electronic monitoring. AIDS (2003) 1.32
Patient-reported nonadherence to HAART is related to protease inhibitor levels. J Acquir Immune Defic Syndr (2000) 1.31
Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav (2005) 1.31
Measuring adherence to highly active antiretroviral therapy: implications for research and practice. Curr HIV/AIDS Rep (2005) 1.20
Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci (2001) 1.20
Antiretroviral concentrations in untimed plasma samples predict therapy outcome in a population with advanced disease. J Infect Dis (2003) 1.18
Patient-clinician relationships and treatment system effects on HIV medication adherence. AIDS Behav (2005) 1.14
Are untimed antiretroviral drug levels useful predictors of adherence behavior? AIDS (2004) 1.13
Conducting cognitive interviews to understand question-response limitations. Am J Health Behav (2003) 1.05
Adherence to antiretroviral therapy: appropriate use of self-reporting in clinical practice. HIV Clin Trials (2001) 1.05
Congruence of three self-report measures of medication adherence among HIV patients. Ann Pharmacother (2000) 1.03
A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother (1999) 0.99
Adherence to combined Lamivudine + Zidovudine versus individual components: a community-based retrospective medicaid claims analysis. AIDS Care (2005) 0.96
Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center. J Acquir Immune Defic Syndr (1999) 0.95
Assessment of adherence to triple antiretroviral treatment including indinavir: role of the determination of plasma levels of indinavir. J Acquir Immune Defic Syndr (2003) 0.94
Assessing the utility of a community pharmacy refill record as a measure of adherence and viral load response in patients infected with human immunodeficiency virus. Pharmacotherapy (2005) 0.90
Antiretroviral medication compliance in patients with AIDS. AIDS Patient Care STDS (1998) 0.90
Predictors for non-adherence to antiretroviral therapy. Sex Health (2004) 0.89
Nonadherence to highly active antiretroviral therapy: clinically relevant patient categorization based on electronic event monitoring. AIDS Res Hum Retroviruses (2002) 0.84
Pros and cons of therapeutic drug monitoring of antiretroviral agents. Curr Opin Infect Dis (2002) 0.84
Memory for memory. Mem Cognit (2001) 0.83
A comprehensive evaluation of survey questions for adherence to antiretroviral medications and exploratory analyses for identifying optimal sets of survey questions. AIDS Patient Care STDS (2006) 0.81
Definition and measurement of adherence to antiretroviral drugs in HIV-1-infected patients. Lancet (1999) 0.79
Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med (2004) 4.38
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41
Hospitalist care and length of stay in patients requiring complex discharge planning and close clinical monitoring. Arch Intern Med (2007) 3.07
Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med (2004) 2.37
Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr (2007) 1.82
Providers' experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med (2009) 1.78
Longer lengths of stay and higher risk of mortality among inpatients of physicians with more years in practice. Am J Med (2011) 1.70
Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial. Drug Alcohol Depend (2010) 1.67
Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol (2005) 1.58
A randomized trial of a multicomponent cessation strategy for emergency department smokers. Acad Emerg Med (2011) 1.55
Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med (2008) 1.46
Interpreting the association between HIV and bone mineral density. AIDS (2007) 1.43
Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. J Subst Abuse Treat (2008) 1.40
Teaching about Substance Abuse with Objective Structured Clinical Exams. J Gen Intern Med (2006) 1.34
Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev (2007) 1.33
A rationale and model for addressing tobacco dependence in substance abuse treatment. Subst Abuse Treat Prev Policy (2006) 1.30
Menopause symptoms in HIV-infected and drug-using women. Menopause (2005) 1.27
A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr (2012) 1.26
Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother (2005) 1.25
HIV infection, drug use, and onset of natural menopause. Clin Infect Dis (2005) 1.24
Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS (2007) 1.22
Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis (2005) 1.22
MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav (2013) 1.14
Comparison of antiretroviral adherence questions. AIDS Behav (2012) 1.14
Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics. Contemp Clin Trials (2009) 1.13
Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors. AIDS Patient Care STDS (2010) 1.12
Microsocial environmental influences on highly active antiretroviral therapy outcomes among active injection drug users: the role of informal caregiving and household factors. J Acquir Immune Defic Syndr (2007) 1.10
Motivational interviewing for improving adherence to antiretroviral medications. Curr HIV/AIDS Rep (2005) 1.09
Effects of methadone on QT-interval dispersion. Pharmacotherapy (2005) 1.04
Unprotected sex among HIV-positive injection drug-using women and their serodiscordant male partners: role of personal and partnership influences. J Acquir Immune Defic Syndr (2006) 1.04
Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey. Harm Reduct J (2006) 1.04
Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention. Clin Infect Dis (2011) 1.04
Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study. J Acquir Immune Defic Syndr (2013) 1.03
Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Subst Use Misuse (2011) 1.03
Intimate partner violence perpetration against main female partners among HIV-positive male injection drug users. J Acquir Immune Defic Syndr (2007) 1.01
Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist care. J Acquir Immune Defic Syndr (2002) 1.00
The impact of methadone induction on cardiac conduction in opiate users. Ann Intern Med (2003) 0.99
The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manage (2004) 0.99
Increased risk of mortality and readmission among patients discharged against medical advice. Am J Med (2012) 0.99
Successful integration of hepatitis C evaluation and treatment services with methadone maintenance. J Addict Med (2010) 0.97
Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection. AIDS Patient Care STDS (2008) 0.95
Hepatitis C management by addiction medicine physicians: results from a national survey. J Subst Abuse Treat (2007) 0.95
Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program. J Subst Abuse Treat (2012) 0.95
Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women. Menopause (2007) 0.94
Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance. AIDS Res Hum Retroviruses (2010) 0.90
A 5-year evaluation of a methadone medical maintenance program. J Subst Abuse Treat (2006) 0.90
Efficacy of an emergency department-based multicomponent intervention for smokers with substance use disorders. J Subst Abuse Treat (2012) 0.90
Self-efficacy and depression as mediators of the relationship between pain and antiretroviral adherence. AIDS Care (2009) 0.89
Update in addiction medicine for the primary care clinician. J Gen Intern Med (2008) 0.89
Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence. Drug Alcohol Depend (2011) 0.88
Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women. Menopause (2008) 0.88
Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney Int (2010) 0.87
Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment. J Subst Abuse Treat (2006) 0.86
Social networks of substance users with HIV infection: application of the Norbeck Social Support Scale. West J Nurs Res (2011) 0.85
Are feelings of responsibility to limit the sexual transmission of HIV associated with safer sex among HIV-positive injection drug users? J Acquir Immune Defic Syndr (2007) 0.85
Primary care affiliations of adults in a methadone program with onsite care. J Addict Dis (2007) 0.85
Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial. Addiction (2014) 0.85
Predictors of current housing status among HIV-seropositive injection drug users (IDUs): results from a 1-year study. AIDS Behav (2008) 0.85
Acceptability of A-CASI by HIV-positive IDUs in a multisite, randomized, controlled trial of behavioral intervention (INSPIRE). J Acquir Immune Defic Syndr (2007) 0.84
The OSCE as a formative evaluation tool for substance abuse teaching. Med Educ (2005) 0.84
Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics. BMC Infect Dis (2011) 0.83
Medications that prolong the QT interval. JAMA (2003) 0.83
Increased Risk of Mortality among Patients Cared for by Physicians with Short Length-of-Stay Tendencies. J Gen Intern Med (2015) 0.83
Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness. Drug Alcohol Depend (2013) 0.82
Incident hyperglycaemia among older adults with or at-risk for HIV infection. Antivir Ther (2011) 0.82
Update in addiction medicine for the generalist. J Gen Intern Med (2007) 0.81
Teaching internal medicine resident physicians about Alcoholics Anonymous: a pilot study of an educational intervention. Subst Abus (2006) 0.81
The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention. AIDS Behav (2014) 0.81
Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users. AIDS Care (2012) 0.81
Diagnosis and treatment of pulmonary embolism in the elderly. Clin Geriatr Med (2003) 0.80
Evaluation of a substance use disorder curriculum for internal medicine residents. Subst Abus (2011) 0.80
ART adherence changes among patients in community substance use treatment: a preliminary analysis from MACH14. AIDS Res Ther (2012) 0.79
Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services. J Subst Abuse Treat (2007) 0.78
Social support networks and primary care use by HIV-infected drug users. J Assoc Nurses AIDS Care (2012) 0.78
Teaching and assessing residents' skills in managing heroin addiction with objective structured clinical examinations (OSCEs). Subst Abus (2013) 0.78
Longitudinal correlates of health care-seeking behaviors among HIV-seropositive injection drug users: how can we intervene to improve health care utilization? J Acquir Immune Defic Syndr (2007) 0.77
Participants' descriptions of social support within a multisite intervention for HIV-seropositive injection drug users (INSPIRE). J Acquir Immune Defic Syndr (2007) 0.76
Attitudes toward menopause in HIV-infected and at-risk women. Clin Interv Aging (2008) 0.76
Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics. Addict Sci Clin Pract (2014) 0.76
False reduction in serum methadone concentrations by BD Vacutainer serum separator tubes (SSTTM). Clin Chem (2006) 0.76
Validity of a self-reported history of a positive tuberculin skin test. A prospective study of drug users. J Gen Intern Med (2004) 0.76
Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review. J Acquir Immune Defic Syndr (2011) 0.75
Antiretroviral Treatment Uptake and Adherence Among Men Who Have Sex With Men and Transgender Women With HIV in Mumbai, India: A Cross-Sectional Study. J Assoc Nurses AIDS Care (2017) 0.75
An intervention to improve advance emergency contraceptive prescribing practices among academic primary care physicians. Contraception (2008) 0.75
A Simple and Powerful Risk-Adjustment Tool for 30-day Mortality Among Inpatients. Qual Manag Health Care (2016) 0.75